MOVE

Company Overview — What Does Movano Inc. Do?

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California. Movano Inc. (MOVE) is classified as a small-cap stock in the Healthcare sector, specifically within the Medical Equipment industry. The company is led by CEO John Mastrototaro and employs approximately 30 people. With a market capitalization of $580M, MOVE is one of the notable companies in the Healthcare sector.

Movano Inc. (MOVE) Stock Rating — Reduce (April 2026)

As of April 2026, Movano Inc. receives a Reduce rating with a composite score of 36.9/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.MOVE ranks #3,174 out of 4,446 stocks in our coverage universe. Within the Healthcare sector, Movano Inc. ranks #474 of 838 stocks, placing it in the lower half of its Healthcare peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

MOVE Stock Price and 52-Week Range

Movano Inc. (MOVE) currently trades at $11.50. The stock lost $0.01 (0.1%) in the most recent trading session. The 52-week high for MOVE is $34.87, which means the stock is currently trading -67.0% from its annual peak. The 52-week low is $0.51, putting the stock 2154.3% above its annual trough. Recent trading volume was 0 shares, suggesting relatively thin trading activity.

Is MOVE Overvalued or Undervalued? — Valuation Analysis

Movano Inc. (MOVE) carries a value factor score of 31/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-sales ratio is 1843.98x, compared to 1.66x for the average Healthcare stock.

At current multiples, Movano Inc. trades at a premium to most Healthcare peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.

Movano Inc. Profitability — ROE, Margins, and Quality Score

Movano Inc. (MOVE) earns a quality factor score of 8/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -398.8%, compared to the Healthcare sector average of -43.5%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -350.6% versus the sector average of -33.1%.

On a margin basis, Movano Inc. reports gross margins of -575.8%, compared to 71.5% for the sector. The operating margin is -5926.1% (sector: -66.1%). Net profit margin stands at -6270.7%, versus -58.7% for the average Healthcare stock. Revenue growth is running at 60.0% on a trailing basis, compared to 10.6% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

MOVE Debt, Balance Sheet, and Financial Health

Movano Inc. has a debt-to-equity ratio of -174.0%, compared to the Healthcare sector average of 32.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 0.57x, which may signal near-term liquidity tightness. Total debt on the balance sheet is $3M. Cash and equivalents stand at $2M.

MOVE has a beta of -4.96, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for Movano Inc. is 31/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.

Movano Inc. Revenue and Earnings History — Quarterly Trend

In TTM 2026, Movano Inc. reported revenue of $439,000 and earnings per share (EPS) of $-21.79. Net income for the quarter was $-20M. Gross margin was -575.8%. Operating income came in at $-18M.

In FY 2025, Movano Inc. reported revenue of $433,000 and earnings per share (EPS) of $-21.79. Net income for the quarter was $-18M. Gross margin was -424.9%. Revenue grew -57.3% year-over-year compared to FY 2024. Operating income came in at $-16M.

In Q3 2025, Movano Inc. reported revenue of $80,000 and earnings per share (EPS) of $-4.73. Net income for the quarter was $-4M. Gross margin was -250.0%. Revenue grew 60.0% year-over-year compared to Q3 2024. Operating income came in at $-3M.

In Q2 2025, Movano Inc. reported revenue of $103,000 and earnings per share (EPS) of $-0.41. Net income for the quarter was $-3M. Gross margin was -251.5%. Operating income came in at $-3M.

Over the past 8 quarters, Movano Inc. has demonstrated a growth trajectory, with revenue expanding from $0 to $439,000. Investors analyzing MOVE stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

MOVE Dividend Yield and Income Analysis

Movano Inc. (MOVE) does not currently pay a dividend. This is common among smaller companies in the Medical Equipment industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Healthcare dividend stocks may want to explore other Healthcare stocks or use the stock screener to filter by dividend yield.

MOVE Momentum and Technical Analysis Profile

Movano Inc. (MOVE) has a momentum factor score of 78/100, indicating strong price momentum with the stock outperforming the majority of the market over recent periods. Stocks with high momentum scores have historically tended to continue their outperformance in the near term. The investment factor score is 25/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 48/100 reflects moderate short selling activity.

MOVE vs Competitors — Healthcare Sector Ranking and Peer Comparison

Within the Healthcare sector, Movano Inc. (MOVE) ranks #474 out of 838 stocks based on the Blank Capital composite score. This places MOVE in the lower half of all Healthcare stocks in our coverage universe. Key competitors and sector peers include ASTRAZENECA PLC (AZN) with a score of 61.4/100, Sol-Gel Technologies Ltd. (SLGL) with a score of 56.6/100, VIEMED HEALTHCARE, INC. (VMD) with a score of 53.4/100, Innoviva, Inc. (INVA) with a score of 52.7/100, and JOHNSON & JOHNSON (JNJ) with a score of 51.7/100.

Comparing MOVE against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full MOVE vs S&P 500 (SPY) comparison to assess how Movano Inc. stacks up against the broader market across all factor dimensions.

MOVE Next Earnings Date

No upcoming earnings date has been announced for Movano Inc. (MOVE) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy MOVE? — Investment Thesis Summary

The quantitative profile for Movano Inc. suggests caution. The quality score of 8/100 flags below-average profitability. The value score of 31/100 indicates premium valuation. Price momentum is positive at 78/100, suggesting the trend favors buyers. High volatility (stability score 31/100) increases portfolio risk.

In summary, Movano Inc. (MOVE) earns a Reduce rating with a composite score of 36.9/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on MOVE stock.

Related Resources for MOVE Investors

Explore more research and tools: MOVE vs S&P 500 comparison, top Healthcare stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare MOVE head-to-head with peers: MOVE vs AZN, MOVE vs SLGL, MOVE vs VMD.